Wordt geladen...
Understanding how long‐acting β(2)‐adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids in asthma – an update
In moderate‐to‐severe asthma, adding an inhaled long‐acting β(2)‐adenoceptor agonist (LABA) to an inhaled corticosteroid (ICS) provides better disease control than simply increasing the dose of ICS. Acting on the glucocorticoid receptor (GR, gene NR3C1), ICSs promote anti‐inflammatory/anti‐asthma ge...
Bewaard in:
| Gepubliceerd in: | Br J Pharmacol |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5120156/ https://ncbi.nlm.nih.gov/pubmed/27646470 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13628 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|